Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
Ipamorelin
Batch #
N/A
Formula
C38H49N9O5
Mol Wt
711.9 g/mol
CAS
170851-70-4
Latest
ISO 17025
8× Testing
99.63%
Purity
VariantIpamorelin
COA ##13126
Labeled10mg
Validation KeyIpamorelin
Tested05/12/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.63%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - Ipamorelin
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Ipamorelin, the first selective growth hormone secretagogue
02
Growth hormone secretagogues: history, mechanism of action, and clinical development
03
Ipamorelin and its effects on pulsatile GH release
04
Synergistic effects of GHRH and growth hormone secretagogues on GH secretion
05
Comparative study of growth hormone secretagogues
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
